Idexx Laboratories Overview
Idexx Laboratories (IDXX) has a ROE of 70.67%, above the Healthcare sector average of 20.86%.
Get informed when a big investor buys or sells
+ Follow70.67%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, IDXX shows a ROE of 70.67%. That is above the Healthcare sector average of 20.86%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 20.86%. Idexx Laboratories is at 70.67%, which is higher that average. That is roughly 238.8% above the sector mean. Use the comparison chart on this page to see how IDXX stacks up against individual peers as well.
Check the historical chart to see whether IDXX's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Idexx Laboratories with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Idexx Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 70.67%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 20.86%, while IDXX is at 70.67%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
